Orexo
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of mental illness and substance use disorders. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product ZUBSOLV® for the treatment of opioid use disorder. - Developed four commercial pharmaceutical products with worldwide approval - Addresses unmet need within the growing space of mental illness and addiction disorders - Broad product portfolio and development pipeline of traditional pharma products and digital therapies - Strategic focus on portfolio expansion through development, licensing and M&A - Strong cash generation from the business area US Pharma enabling to invest in future growth
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-30 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Orexo
|
Swedish | 76.3 KB | |
| 2025-06-30 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Orexo
|
English | 76.6 KB | |
| 2025-06-25 11:38 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 9.8 KB | |
| 2025-06-19 16:40 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 9.9 KB | |
| 2025-06-18 18:00 |
Transaction in Own Shares
Emission och återköp av C-aktier
|
Swedish | 166.4 KB | |
| 2025-06-18 18:00 |
Transaction in Own Shares
Issue and repurchase of class C shares
|
English | 168.1 KB | |
| 2025-05-08 17:15 |
AGM Report
Report from Orexo AB’s annual general meeting 8 May 2025
|
English | 175.7 KB | |
| 2025-05-08 17:15 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från Orexo AB:s årsstämma den 8 maj 2025
|
Swedish | 148.7 KB | |
| 2025-05-06 08:00 |
Quarterly Report
|
Swedish | 4.6 MB | |
| 2025-05-06 08:00 |
Quarterly Report
|
English | 4.6 MB | |
| 2025-02-06 08:00 |
Annual Report
|
Swedish | 5.3 MB | |
| 2025-02-06 08:00 |
Annual Report
|
English | 5.3 MB | |
| 2024-12-18 11:45 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från Orexo AB:s extra bolagsstämma den 18 december 2024
|
Swedish | 124.4 KB | |
| 2024-12-18 11:45 |
Declaration of Voting Results & Voting Rights Announcements
Report from Orexo AB’s extraordinary general meeting, December 18 2024
|
English | 127.1 KB | |
| 2024-12-15 21:00 |
Regulatory News Service
Orexo har löst patenttvisten mot Sun Pharmaceutical Industries för Zubsolv i USA
|
Swedish | 130.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
Antibiotice S.A. | Romania | ATB |